Phase I trial of IPG1094 in solid tumors and multiple myeloma
Latest Information Update: 09 Dec 2021
Price :
$35 *
At a glance
- Drugs IPG 1094 (Primary)
- Indications Multiple myeloma; Solid tumours
- Focus Adverse reactions
- 09 Dec 2021 New trial record